This is the first in a series of 6 podcasts on the ins and outs of drug development. In it, we discuss the journey that a promising molecule takes to develop into a life-saving medication and the people that steer that rigorous work. How does a company go from a molecule to the actual medication? What are the steps? Who is involved? What are the processes and barriers? And what does that process look like in real-time? Thanks to a kind invitation from Dr. Scott Struthers, chairman of Crinetics Pharmaceutical and his team, PWN readers and listeners will get an unfettered look at a young company’s efforts to develop new drugs to solve unmet needs in acromegaly, Cushing’s and rare neuroendocrine disease. Don’t miss it!
Photo by Pixabay
© 2020, Pituitary World News. All rights reserved.